Healthcare Utilization and Statin Re‐Initiation Among Medicare Beneficiaries With a History of Myocardial Infarction

par John N. Booth, Lisandro D. Colantonio, Robert S. Rosenson, Monika M. Safford, Ligong Chen, Meredith L. Kilgore, Todd M. Brown, Benjamin Taylor, Ricardo Dent, Keri L. Monda, Paul Muntner, Emily B. Levitan
Publié 2018

Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry

par Michael G. Nanna, Ann Marie Navar, Tracy Y. Wang, Xiaojuan Mi, Salim S. Virani, Michael J. Louie, L. Veronica Lee, Anne C. Goldberg, Veronique L. Roger, Jennifer Robinson, Eric D. Peterson
Publié 2018

SIMULTANEOUS DETERMINATION OF CEFTRIAXONE SODIUM AND STATIN DRUGS IN PHARMACEUTICAL FORMULATIONS AND HUMAN SERUM BY RP-HPLC

par SULTANA,NAJMA, ARAYNE,M. SAEED, SHAHZAD,WASEEM
Publié 2010

Synthesis and biological evaluation of novel β-cyclodextrin-fluvastatin conjugates

par Mariacristina Nicolosi, Francesco Bellia, Maria Laura Giuffrida, Stefania Zimbone, Valentina Oliveri, Graziella Vecchio
Publié 2021

Beneficial effects of pre-stroke statins use in cardioembolic stroke patients with atrial fibrillation: a hospital-based retrospective analysis

par Dariusz Kotlęga, Monika Gołąb-Janowska, Agnieszka Meller, Anna Bajer-Czajkowska, Agnieszka Zembroń-Łacny, Przemysław Nowacki, Maciej Banach
Publié 2019

Atorvastatin does not ameliorate nephrogenic diabetes insipidus induced by lithium or potassium depletion in mice

par Maria L. Thomsen, Camilla Grønkjær, Anna Iervolino, Soham Rej, Francesco Trepiccione, Birgitte M. Christensen
Publié 2021

Effect of different doses of statins on the development of type 2 diabetes mellitus in patients with myocardial infarction

par Gruzdeva O, Uchasova E, Dyleva Y, Akbasheva O, Karetnikova V, Shilov A, Barbarash O
Publié 2017

Prevention of Osteoarthritis Progression by Statins, Targeting Metabolic and Inflammatory Aspects: A Review

par Behzad Heidari, Mansour Babaei, Behnaz Yosefghahri
Publié 2021

A Narrative Review of Statin-Induced Rhabdomyolysis: Molecular Mechanism, Risk Factors, and Management

par Safitri N, Alaina MF, Pitaloka DAE, Abdulah R
Publié 2021

Influence of Statin Therapy on the Incidence of Cardiovascular Events, Cancer, and All-Cause Mortality in People Living With HIV: A Meta-Analysis

par Yanping Li, Zhandi Wang, Haimei Xia, Ju Zhang
Publié 2021

Impact of Prior Statin Use on Reperfusion Rate and Stroke Outcomes in Patients Receiving Endovascular Treatment

par Sang-Hwa Lee, Min Uk Jang, Yerim Kim, So Young Park, Chulho Kim, Yeo Jin Kim, Jong-Hee Sohn
Publié 2021

A Case Report of Severe Rhabdomyolysis after Lovastatin and Diltiazem Consumption

par M Baradaran, A Ahmadi Ahangar
Publié 2010

Grip strength as a frailty diagnostic component in geriatric inpatients

par Dudzińska-Griszek J, Szuster K, Szewieczek J
Publié 2017

The Effect of Cardiovascular Medications on Disease-Related Outcomes in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis

par Wan-Tong Zhang, Xu-Jie Wang, Chun-Miao Xue, Xin-Yu Ji, Lin Pan, Wei-Liang Weng, Wei-Liang Weng, Qiu-Yan Li, Qiu-Yan Li, Guo-Dong Hua, Bao-Chen Zhu
Publié 2021

Reducing Low‐Density Lipoprotein Cholesterol After Myocardial Infarction in Older Individuals, Levels Versus Change: Can Observational Studies Answer the Questions?

par Lewis H. Kuller
Publié 2018

Long-Term Abnormalities of Lipid Profile After a Single Episode of Sepsis

par Nicholas Felici, Da Liu, Josh Maret, Mariana Restrepo, Yuliya Borovskiy, Yuliya Borovskiy, Jihane Hajj, Wesley Chung, Krzysztof Laudanski, Krzysztof Laudanski, Krzysztof Laudanski
Publié 2021

Evaluation of Low-density Lipoprotein Cholesterol Target Attainment Rates According to the 2016 and 2019 European Society of Cardiology/ European Atherosclerosis Society Dyslipidem...

par Barış Şimşek, Duygu İnan, Tufan Çınar, Ahmet Cagdas-Yumurtaş, Veysel Ozan-Tanık, Gonul Zeren, İlhan İlker-Avcı, Can Yücel-Karabay, Barış Güngör, Lale Tokgozoğlu
Publié 2021

Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy

par Pierandrea Vinci, Emiliano Panizon, Letizia Maria Tosoni, Carla Cerrato, Federica Pellicori, Filippo Mearelli, Chiara Biasinutto, Nicola Fiotti, Filippo Giorgio Di Girolamo, Gianni Biolo
Publié 2021

Association of Contemporary Statin Pretreatment Intensity and LDL-C Levels on the Incidence of STEMI Presentation

par Ziv Dadon, Mady Moriel, Zaza Iakobishvili, Elad Asher, Tal Y. Samuel, Dov Gavish, Michael Glikson, Shmuel Gottlieb
Publié 2021

Determinants of Statin Initiation Among Adult Diabetic Patients in Bonga, Ethiopia

par Kebede zelalem B, Feyisa D
Publié 2020